Transforming the
basic biomedical knowledge
into economic and social value

Barcelona, February 23, 2011 .- Janus Developments has acquired the rights to develop and operate a medical device developed at the Hospital General de Granollers from a figment of his Chief of Anesthesiology, Dr. Pere Poch . This device, which facilitates access to the airway through the mouth, reducing interference from the tongue, is particularly useful for introducing the LMA as a precursor to life-support procedures or anesthesia. The introduction of the LMA requires some training and usually the assistance of two people, so that the facilitator have a system would simplify the procedure and make it easy for non experts or having to work without assistance, particularly in situations emergency, fire, etc. This is the first license to technology developed by the Hospital General de Granollers, through the collaboration of the inventor with the Research and Innovation Unit of the hospital and the intermediary and the firm support Montpalau Enginyeria SL.

The first pilot-scale devices made available during the first quarter of 2011. The goal is to complete its industrialization Janus, build a strong intellectual property position and demonstrate the clinical feasibility of the device. It is expected that two years before the product is ready for marketing by a company specialized in the sector. Each year there are about 130 million anesthesia procedures throughout the world, some of which could benefit from this new device

Luis Ruiz-Avila, Director of Janus, considers the case of laryngeal mask introducer is a good example of mainstreaming the business model of Janus, which aims to act as a bridge between biomedical knowledge and the market by increasing the chances of solving unmet medical needs and also demonstrating that you can do to generate returns for their shareholders and institutions originators of the technology. For Ruiz-Avila, this case also demonstrates that there is a huge reservoir of biomedical knowledge applicable in our environment, and that any institution that is in contact with the real problems of patients has the potential to generate economic and social value from their inventions.

More
Carmen Perez
Anàlisi Institutional Relations
Barcelona Science Park
Torres R + I + D
C / Baldiri Reixac, 4
tel. 934034568
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Janus Developments
Formed in March 2009, Janus Developments is located at the Barcelona Science Park, and attached to the PCB-Santander Bioincubator and has 7 employees and a network of 40 partners and national and international consultants involved in the development of project based needs. It is currently developing 11 projects which patents were originated by universities and research centers. It also collaborates on a timely basis in the definition and implementation of research and development strategy of various companies and foundations (including the Fundació Pasqual Maragall). It  also run on temporary Archivel biotech companies like Pharma, responsible for the development of RUTI latent TB, currently in clinical trials on patients in South Africa. Its financial partners are Ferrer Internacional, Enantia and Caixa Catalunya. In 2010 the company billed for services and licenses € 700,000, with an R & D investment of 370,000 €.

Fundació Hospital Asil de Granollers / Hospital General de Granollers
The Foundation Hospital / Asylum Granollers is a health care center, social health and social integrated into the Public Health Network Utilization. It is the reference hospital of Vallès Oriental. Research and teaching are growing activities in the institution. 2007, he created the Research and Innovation Unit of the Hospital General de Granollers with the aim of promoting research and transfer of research results. The unit coordinates the Ethics Committee of Clinical Research (CEIC FHAG), the Research Committee, project management and collaboration contracts and clinical trials. Participate in clinical trials (phases II, III and IV) of oncology, HIV, cardiology, among others. Recently, we have defined innovation policy of the center and the research institutions. Respect to teaching, Granollers General Hospital has signed an agreement with the Universitat Internacional de Catalunya (UIC) for the training of medical students. Thus, Granollers General Hospital becomes a teaching hospital.

Montpalau Enginyeria SL.
Newly created company focuses its current activity on the technological development of the medical device designed at the General Hospital of Granollers and business aims to support technological devices, mainly in the health field.